- Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tu…
Number of the records: 1  

Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial

  1. Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial / Mego M. ... [et al.]. Onkológia Roč. 17, č. 4 (2022), s. 298
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all